Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingInterventionalPhase 2

Incisional Hernia Prevention After Open Hepatectomy by Small Tissue Bite Fascial Closure: A Randomized Clinical Trial

NCT ID: NCT04982653Sponsor: M.D. Anderson Cancer CenterLast updated: 2026-05-26

Summary

This clinical trial compares two different kinds of surgical closing techniques, short stitch suture or traditional suture, in patients who are having liver tumor surgery. This study may help researchers learn if one technique can lower the chances of developing a hole in the wall of the abdomen (an abdominal hernia) at the incision site better than the other.

Detailed description

PRIMARY OBJECTIVE: I. To assess whether small bites abdominal wall closure reduces the risk of developing incisional hernia following liver surgery. SECONDARY OBJECTIVES: I. To compare short-term perioperative outcomes between small bites and typical fascial closure technique. II. To assess the hernia incidence rate of short stich versus (vs.) standard closure in subgroups of patients with inverted-L or midline incisions. III. To assess the hernia incidence rate of Kawaguchi-Gayet hepatectomy complexity classifications I/II vs. III (hernia rate by extent of hepatectomy). IV. To assess the hernia incidence rate of preoperative chemotherapy or no preoperative chemotherapy (hernia rate by exposure to preoperative chemotherapy). V. To assess impact of small bites abdominal wall closure on health care quality of life following liver surgery. VI. To assess safety of small tissue bites fascial closure suture technique versus conventional fascial closure following hepatectomy. OUTLINE: Patients are randomized to 1 of 2 arms. ARM I (INTERVENTION): Patients undergo hepatectomy as planned using small bites fascial method for abdominal wall closure. ARM II (CONTROL): Patients undergo hepatectomy as planned using conventional fascial method for abdominal wall closure. After completion of study, patients are followed up at 1-4 weeks, and then at 3, 6, and 12 months.

Arms & interventions

  • OtherQuality-of-Life Assessment

    Ancillary studies

  • ProcedureSurgical Procedure

    Undergo hepatectomy using small bites fascial method for abdominal wall closure

  • ProcedureSurgical Procedure

    Undergo hepatectomy using conventional fascial method for abdominal wall closure

Outcome measures

Primary

  • Radiographic incidence rate of incisional hernia

    Definition of incisional hernia will be based on the European Hernia Society: Any abdominal wall gap with or without a bulge in the area of a postoperative scar perceptible or palpable by clinical examination or imaging. Assessment of the primary outcome will occur at 3, 6, and 12 months with a computed tomography scan/magnetic resonance imaging. Scans will be read and assessed for incisional hernia by 3 independent assessors blinded to the allocation. A correlation coefficient will be determined for their assessments. The cumulative incidence rate of incisional hernia at 12 months will be estimated, along with the 95% confidence interval.

    Time frame: Up to 12 months after surgery

Secondary

  • Surgical site infection

    Time frame: Up to 90 days after surgery

  • Surgical site occurrence

    Time frame: Up to 90 days after surgery

  • Surgical site occurrence requiring procedural intervention

    Time frame: Up to 90 days after surgery

  • Postoperative complications

    Time frame: Up to 90 days after surgery

  • Need for reoperation

    Time frame: Up to 90 days after surgery

  • Need for reoperation secondary to complication of abdominal closure

    Time frame: Up to 90 days after surgery

  • Length of hospital stay (postoperatively)

    Time frame: Up to 90 days after surgery

  • Any readmission related to hernia repair

    Time frame: Up to 30 days after surgery

  • Health-related quality of life assessment

    Time frame: Up to 12 months after surgery

  • Incidence of adverse events (AEs)

    Time frame: Up to 90 days after surgery

Eligibility criteria

Sex: AllAge: 18 Years and olderHealthy volunteers: No
Inclusion Criteria: * Patients undergoing hepatectomy for malignant diagnosis (primary or secondary) from 5/1/2021 through 11/1/2024 will be eligible for inclusion in this study * Elective surgery * Age \>= 18 * Planned midline laparotomy incision or inverted-L incision Exclusion Criteria: * Pre-existing abdominal hernia * History of mesh placement at prior laparotomy * Pregnant women

Study locations (1)

M D Anderson Cancer Center

Houston, Texas, 77030

Recruiting
Timothy E. Newhook · Contact
Timothy E. Newhook · Principal Investigator